| ISSN: 1139-8736 Depósito Legal: B-37271-2002 Copyright: © Silvia Montero Martínez |
EVENT_ATTRIBUTE
HAVE-NEOPLASM_survival-rate (scalar-disease-event-attribute): %
|
CANCER
|
||
| cancer-specific survival |
3
|
|
|
DISEASE
|
||
|
849
|
survival in advanced hodgkin's disease |
2
|
|
CARCINOMA
|
||
|
1022
|
survival in epidermoid carcinoma |
2
|
|
LEUKEMIA
|
||
|
494
|
survival in acute myelogenous leukemia |
2
|
|
HEPATOBLASTOMA
|
||
|
51
|
survival from advanced hepatoblastoma |
2
|
|
TERATOMA
|
||
|
38
|
survival for immature teratoma |
2
|
|
CANCER
|
||
| 78% 10-year survival for cancer |
4
|
|
| 20-year survival rate of 98% for low-risk cancer |
3
|
|
| overall 3-year survival of 90% in breast cancer |
4
|
|
| 60% overall 5-year survival in breast cancer |
5
|
|
| 20% 3-year survival rate in lung cancer |
3
|
|
| 50% 3-year survival in stomach cancer |
3
|
|
| 96% 5-year survival rate in breast cancer |
5
|
|
| 98% 5-year survival rate in breast cancer |
2
|
|
| 4% 5-year survival rate in pancreatic cancer |
2
|
|
|
TUMOR
|
||
| 29% 5-year survival rate in tumors |
2
|
|
| 5-year survival rate of 40% in tumors |
3
|
|
| 90% 5-year survival rate with no residual tumor |
2
|
|
| 87% disease-free survival for breast tumors |
2
|
|
| 10% survival at 8 years for lung tumors |
2
|
|
| high survival rate (85%) for breast tumors |
2
|
|
| 87% disease-free survival in residual tumors |
3
|
|
| 30% survival rate for invasive tumors |
3
|
|
|
DISEASE
|
||
| 60% 5-year disease-free survival rates for disease |
2
|
|
| disease-free survival of 16% in hodgkin's disease |
2
|
|
| 5-year disease-free survival rate of 50%-80% | ||
|
CARCINOMA
|
||
| 20% 2-year survival rate in carcinoma |
3
|
|
| 5-year disease-free survival (85%) for carcinoma |
3
|
| ISSN: 1139-8736 Depósito Legal: B-37271-2002 Copyright: © Silvia Montero Martínez |